Avalon Globocare Corp. filed an application for listing on the Nasdaq Capital Market.

The company has seen growth in developing its cell-based technologies, and listing on the Nasdaq Capital Market will provide greater exposure as it executes on upcoming milestones, President and CEO David Jin said in a news release.

Freehold, N.J.-based Avalon Globocare also provides healthcare services and manages healthcare facilities in the U.S. and China.